CDH5 and neoplasm: As with pancreatic neuroendocrine tumours [46 ], LIGHT-VTP therapy led to the normalization of angiogenic tumour vessels in the NFpp10-GBM mouse model, which was characterized by the maturation of pericytes, re-establishment of vessel integrity through VE-Cadherin upregulation and improved tumour perfusion [42].